London
· Delayed Price · Currency is GBP · Price in GBXMaxCyte Statistics
Total Valuation
MaxCyte has a market cap or net worth of GBP 348.78 million. The enterprise value is 247.67 million.
| Market Cap | 348.78M |
| Enterprise Value | 247.67M |
Important Dates
The next estimated earnings date is Thursday, March 13, 2025.
| Earnings Date | Mar 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MaxCyte has 105.69 million shares outstanding. The number of shares has increased by 1.47% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 105.69M |
| Shares Change (YoY) | +1.47% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 1.28% |
| Owned by Institutions (%) | 60.64% |
| Float | 96.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.13 |
| PB Ratio | 2.18 |
| P/TBV Ratio | 2.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.29 |
| EV / Sales | 7.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.64 |
Financial Position
The company has a current ratio of 9.81, with a Debt / Equity ratio of 0.09.
| Current Ratio | 9.81 |
| Quick Ratio | 8.99 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.86 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -16.00% and return on invested capital (ROIC) is -12.05%.
| Return on Equity (ROE) | -16.00% |
| Return on Assets (ROA) | -11.25% |
| Return on Capital (ROIC) | -12.05% |
| Revenue Per Employee | 237,912 |
| Profits Per Employee | -186,452 |
| Employee Count | 143 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 0.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.69% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -7.69% |
| 50-Day Moving Average | 290.50 |
| 200-Day Moving Average | 321.00 |
| Relative Strength Index (RSI) | 62.87 |
| Average Volume (20 Days) | 62,889 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MaxCyte had revenue of GBP 34.02 million and -26.66 million in losses. Loss per share was -0.26.
| Revenue | 34.02M |
| Gross Profit | 29.25M |
| Operating Income | -34.61M |
| Pretax Income | -26.66M |
| Net Income | -26.66M |
| EBITDA | -31.36M |
| EBIT | -34.61M |
| Loss Per Share | -0.26 |
Balance Sheet
The company has 114.77 million in cash and 13.67 million in debt, giving a net cash position of 101.11 million or 0.96 per share.
| Cash & Cash Equivalents | 114.77M |
| Total Debt | 13.67M |
| Net Cash | 101.11M |
| Net Cash Per Share | 0.96 |
| Equity (Book Value) | 159.14M |
| Book Value Per Share | 1.51 |
| Working Capital | 115.86M |
Cash Flow
In the last 12 months, operating cash flow was -14.03 million and capital expenditures -1.80 million, giving a free cash flow of -15.84 million.
| Operating Cash Flow | -14.03M |
| Capital Expenditures | -1.80M |
| Free Cash Flow | -15.84M |
| FCF Per Share | -0.15 |
Margins
Gross margin is 85.98%, with operating and profit margins of -101.74% and -78.37%.
| Gross Margin | 85.98% |
| Operating Margin | -101.74% |
| Pretax Margin | -78.37% |
| Profit Margin | -78.37% |
| EBITDA Margin | -92.18% |
| EBIT Margin | -101.74% |
| FCF Margin | n/a |
Dividends & Yields
MaxCyte does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.47% |
| Shareholder Yield | -1.47% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MaxCyte has an Altman Z-Score of 6.72.
| Altman Z-Score | 6.72 |
| Piotroski F-Score | n/a |